Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A1 | O15245 | 1/20 | 0.88 |
| ▸ | GRK2 | P25098 | 1/20 | 0.80 |
| ▸ | SYNJ2 | O15056 | 3/20 | 0.49 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.33 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.33 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.33 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.33 |
| ▸ | SELP | P16109 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Paeoniflorin SCHEMBL15236857 | 1.00 | SLC22A1 (0.88) | SLC22A1GRK2SYNJ2MAOBALDH1A1 | |
| Paeoniflorin SCHEMBL13615628 | 1.00 | SLC22A1 (0.88) | SLC22A1GRK2SYNJ2MAOBALDH1A1 | |
| Paeoniflorin SCHEMBL20009472 | 1.00 | SLC22A1 (0.88) | SLC22A1GRK2SYNJ2MAOBALDH1A1 | |
| Paeoniflorin SCHEMBL24935593 | 1.00 | SLC22A1 (0.88) | SLC22A1GRK2SYNJ2MAOBALDH1A1 | |
| Paeoniflorin SCHEMBL14088840 | 1.00 | SLC22A1 (0.88) | SLC22A1GRK2SYNJ2MAOBALDH1A1 | |
| Paeoniflorin SCHEMBL24927267 | 1.00 | SLC22A1 (0.88) | SLC22A1GRK2SYNJ2MAOBALDH1A1 | |
| Paeoniflorin SCHEMBL549033 | 1.00 | SLC22A1 (0.88) | SLC22A1GRK2SYNJ2MAOBALDH1A1 | |
| Paeoniflorin SCHEMBL29396890 | 1.00 | SLC22A1 (0.88) | SLC22A1GRK2SYNJ2MAOBALDH1A1 | |
| Paeoniflorin SCHEMBL22649040 | 1.00 | SLC22A1 (0.88) | SLC22A1GRK2SYNJ2MAOBALDH1A1 | |
| Paeoniflorin SCHEMBL7625329 | 0.99 | SLC22A1 (0.87) | SLC22A1GRK2SYNJ2MAOBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160184298-A1 | INHIBITORS AND ENHANCERS OF URIDINE DIPHOSPHATE-GLUCURONOSYLTRANSFERASE 2B (UGT2B) | NAT DEFENSE MEDICAL CT (TW) | 2016-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160184298-A1 | INHIBITORS AND ENHANCERS OF URIDINE DIPHOSPHATE-GLUCURONOSYLTRANSFERASE 2B (UGT2B) | UGT2B7, UGT2B17, UGT1A10 | SLC22A1 175/4885GRK2 951/4885SYNJ2 1660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.